Keyword: U.S. Securities and Exchange Commission
News
11.06.2013
- A former Bristol-Myers Squibb finance executive on Monday pleaded guilty to an insider trading charge, admitting to buying stock options in a biotechnology company that the...
News
21.12.2012
- U.S. drugmaker Eli Lilly agreed on Thursday to pay $29 million to settle civil charges that its subsidiaries made improper payments to foreign government officials to win business...
News
26.05.2011
- Corporate whistleblowers could score multi-million-dollar payouts for reporting financial wrongdoing under a new program approved by U.S. securities regulators on Wednesday. A...
News
07.04.2011
- A lawyer and a trader were accused by federal prosecutors of running a 17-year conspiracy to trade on corporate merger secrets stolen from three of the nation's most powerful law...
News
30.03.2011
- Certificates related to Sanofi-Aventis's $20.1 billion acquisition of U.S. biotech firm Genzyme could begin trading on Nasdaq as soon as April 4, depending on the outcome of its...
